Biodegradable polymeric nanocarriers for pulmonary drug delivery

Area of Science:

• Nanotechnology and Pharmaceutical Sciences
• Biomaterials Engineering
• Respiratory Medicine

Background:

• Pulmonary drug delivery offers a non-invasive route for local and systemic treatments.
• Key advantages include large surface area, thin epithelia, high blood flow, and bypassing first-pass metabolism.
• This route is suitable for delivering diverse therapeutic agents.

Purpose of the Study:

• To review the development and application of biodegradable polymers in nanocarrier-based pulmonary drug delivery.
• To highlight strategies for delivering drugs, peptides, proteins, genes, siRNA, and vaccines via the lungs.
• To explore nanoparticle design for optimized pulmonary administration.

Main Methods:

• Focus on biodegradable polymers for nanocarrier formulation.
• Review of nanoparticle strategies for pulmonary drug delivery.
• Analysis of applications for various therapeutic payloads.

Main Results:

• Nanoparticles can be engineered for controlled deposition and sustained release.
• Particle size is crucial for evading alveolar macrophage clearance or enhancing transport.
• Biodegradable nanocarriers offer potential for reduced dosing frequency.

Conclusions:

• Material selection (natural vs. synthetic polymers) is critical for desired nanoparticle characteristics.
• Key design considerations include biocompatibility, size, charge, drug release kinetics, and degradation rate.
• Optimized nanocarriers can enhance the efficacy and safety of pulmonary drug delivery.